Skip to main content
Clinical Trials/ISRCTN14366792
ISRCTN14366792
Terminated
未知

Impact of telemedicine activation of older patients with polypharmacy: a randomised acceptance and feasibility study in Switzerland

niversity of Zurich0 sites0 target enrollmentMarch 29, 2019

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
niversity of Zurich
Status
Terminated
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 29, 2019
End Date
May 31, 2021
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversity of Zurich

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients insured at SWICA
  • 2\. German\-speaking
  • 3\. 60 years or older
  • 4\. Using at least five different drugs, at least three original packages over the last 12 months and at least one month distance in between. Exception of this 12 months rule and included in the data are androgens, vitamin B12, antineoplastic and immunemodulating agents and drugs for treating osteoporosis. Excluded drugs are topical (including dermatologicals, nasal\-, throat\-, cough and cold preparations, transdermal opioids), intravenous and homeopathic drugs, vaccines, surgical dressings, contrast agents as well as products from these pharmaceutical companies (Ceres®, Similisan®, Omnida®, Spagyros® and Vogel®)
  • 5\. Signed Informed Consent after being informed

Exclusion Criteria

  • Patients insured at SWICA with a GP guided healthcare plan

Outcomes

Primary Outcomes

Not specified

Similar Trials